Distribution of Eli Lilly COVID-19 therapy paused in 8 states over variant concerns

Visits: 6

Federal health authorities have paused distribution of Eli Lilly’s monoclonal antibody cocktail in eight states over COVID-19 variant efficacy concerns. Read More Go To Source